LEO Pharma Open Innovation

Join us in discovering new treatments for people with skin conditions

What is open innovation?

LEO Pharma Open Innovation is a collaborative space created to explore partnerships and collaborations in early drug research by offering free access to selected research capabilities. External partners can test their own molecules for disease-relevant effect, without having to disclose confidential information, such as the molecular structure, and with no strings attached.


Intellectual property

The Partner's existing intellectual property rights in submitted compounds remain with the Partner throughout the entire process. More about intellectual property.

Data sharing

LEO Pharma will share all test data and conclusions on your substance with you and you only, unless otherwise mutually agreed. More about data sharing.


LEO Pharma acknowledges and respects the need for confidentiality, in particular when it comes to disclosing information about compounds of commercial value. More about confidentiality.